[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Bouvier et al., 1990 - Google Patents

Peptide substrate specificity of the membrane-bound metalloprotease of Leishmania

Bouvier et al., 1990

Document ID
5471960539902327329
Author
Bouvier J
Schneider P
Etges R
Bordier C
Publication year
Publication venue
Biochemistry

External Links

Snippet

Revised Manuscript Received June 27, 1990 abstract: The promastigote surface protease (PSP) of Leishmania is a neutral membrane-bound zinc enzyme. The protease has no exopeptidase activity and does not cleave a large selection of substrates with chromogenic …
Continue reading at pubs.acs.org (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6402—Proteinases Endopeptidases (3.4.21-3.4.25) derived from animal tissue from non-mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases Endopeptidases (3.4.21-3.4.25)
    • C12N9/52—Proteinases Endopeptidases (3.4.21-3.4.25) derived from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/07—Tetrapeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids

Similar Documents

Publication Publication Date Title
Bouvier et al. Peptide substrate specificity of the membrane-bound metalloprotease of Leishmania
Leung et al. Protease inhibitors: current status and future prospects
Bieth Elastases: catalytic and biological properties
Otto et al. Cysteine proteases and their inhibitors
Caughey et al. Angiotensin II generation by mast cell α-and β-chymases
Orlowski et al. Evidence for the presence of five distinct proteolytic components in the pituitary multicatalytic proteinase complex. Properties of two components cleaving bonds on the carboxyl side of branched chain and small neutral amino acids
Li et al. Peptide. alpha.-keto ester,. alpha.-keto amide, and. alpha.-keto acid inhibitors of calpains and other cysteine proteases
Adams et al. Novel inhibitors of the proteasome and their therapeutic use in inflammation
Gonzalez et al. Proteasome activity is required for the stage-specific transformation of a protozoan parasite.
Kam et al. Granzymes (lymphocyte serine proteases): characterization with natural and synthetic substrates and inhibitors
Wilk et al. Inhibition of rabbit brain prolyl endopeptidase by N‐benzyloxycarbonyl‐prolyl‐prolinal, a transition state aldehyde inhibitor
Davies et al. Protein damage and degradation by oxygen radicals. IV. Degradation of denatured protein.
Mumford et al. A zinc metalloendopeptidase associated with dog pancreatic membranes.
Nakagawa et al. The role of lysosomal proteinases in MHC class Il‐mediated antigen processing and presentation
Dash et al. Aspartic peptidase inhibitors: implications in drug development
Kessler et al. Pseudomonas protease. Purification, partial characterization, and its effect on collagen, proteoglycan, and rabbit corneas.
Gaczynska et al. Caretaker or undertaker? The role of the proteasome in aging
Gruber et al. Human immunodeficiency virus type 1 protease inhibitor attenuates Candida albicans virulence properties in vitro
Cardozo et al. A 3, 4-dichloroisocoumarin-resistant component of the multicatalytic proteinase complex
Alvarez et al. Update on relevant trypanosome peptidases: Validated targets and future challenges
Beatriz Vermelho et al. Trypanosomatidae peptidases: a target for drugs development
CA2227198A1 (en) Cysteine protease inhibitors for use in treatment of ige mediated allergic diseases
Mäkinen et al. An endo-acting proline-specific oligopeptidase from Treponema denticola ATCC 35405: evidence of hydrolysis of human bioactive peptides
Valdivieso et al. Leishmania mexicana: identification and characterization of an aspartyl proteinase activity
Fernández et al. Progress in metallocarboxypeptidases and their small molecular weight inhibitors